Antonio Brugarolas Masllorens

Antonio Brugarolas Masllorens
HEAD OF MEDICAL ONCOLOGY SERVICE
See more specialists on
Alicantealicante
en/medical-staff/oncologist
Dr. Antonio Brugarolas Masllorens is an eminent oncologist, renowned for his contributions to the field of medicine. He earned his Doctorate in Medicine in 1984 from the Universidad de Navarra, further solidifying his academic training with a Bachelor of Medicine degree from the Universidad de Barcelona. He currently leads the Medical Oncology Department at Hospital Quirón salud , where he has been active since 2000. Among his most notable publications is the article "Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies," published in Frontiers in Oncology in June 2022. His career has been recognized with the Cross of Officer of the Civil Merit, awarded by the Gobierno de España in 1994. Furthermore, Dr. Brugarolas is a member of the American Association for Cancer Research, which underscores his commitment to research and the advancement of cancer treatment.
Key information
- Officer's Cross of Civil Merit1994
- Latest Publication:Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis
Professional Details
Hospital Quirónsalud Torrevieja
HEAD OF MEDICAL ONCOLOGY SERVICE
September 2000 -
Present
Clínica Universidad de Navarra
Director of the Department of Oncology and Professor of Oncology
January 1980 - January 2000
Hospital Universitario Central de Asturias
Head of the Medical Oncology Service
January 1973 - January 1980
Roswell Park Cancer Institute
Resident Fellow
January 1970 - January 1973
Study
Bachelor of Medicine
Universidad de Barcelona
1967
Doctorate
Universidad de Navarra
1984
Another qualification
Resident Fellow at the Roswell Park Cancer Institute
Oncology
Universidad de Navarra
January 1980 - January 2000
Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis
Article
Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study.
Journal Article
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Journal Article
Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies.
Journal Article, Review
Therapeutic Drug Monitoring of Erlotinib in Non-Small Cell Lung Carcinoma: A Case Study.
Journal Article
Regional treatment of locally advanced sarcoma and melanoma of the extremity by isolated perfusion with TNF alpha and melphalan associated with hyperthermia
Article
Officer's Cross of Civil Merit
Gobierno de España
Make an appointment with this professional
Hospital Quirónsalud Torrevieja
© 2026 Quirónsalud - All rights reserved






















